Berlin’s Apheris and Ginkgo bring pharma giants together to train AI on 10,000 antibodies

Ginkgo Datapoints and Berlin-based Apheris today announced that the Antibody Developability Consortium has kicked off with its founding members. The Consortium is a new industry collaboration designed...

Read the full story at Tech.eu ↗

Timeline · 1 report

2026-09-29 12:00 · Tech.eu
Berlin’s Apheris and Ginkgo bring pharma giants together to train AI on 10,000 antibodies

More stories

NVIDIA Open Agent Safety Platform: A Reference for Continuous In-Silicon Agent Monitoring — NVIDIA Technical Blog
The Future Is for Everyone: Muse for Small Business — Meta Newsroom
How we found 24 Android vulnerabilities using our open source AI security agent — GitHub Blog
OpenAI expands review of model behavior after more rogue agent incidents emerge — CNBC Technology
Introducing Claude Sonnet 5.5 on AWS — AWS Machine Learning Blog
OpenAI Scraps Debut of AI Model as It Sets New Guardrails — Bloomberg AI
AMD will acquire Fei-Fei Li's World Labs for $8.2 billion — TechCrunch AI
Anthropic warns of ‘existential risks to humanity’ in IPO prospectus — Financial Times AI

Get the daily brief of stories like this at 6:30 every morning →